coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Healthier West Wirral PCN, Wirral (LAD) · Health Inequalities Profile

    PCN U79121 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    67,559

    Registered population

    52.9% aged 18–64

    30.9%

    Aged 65+

    ICB 19.0% · England 17.9%

    4.3%

    Ethnic minority (non-White)

    2.0% Asian · England 9.6%

    4.8%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~3,449

    Core20 residents (est.)

    Resident basis; registered basis ~2,865 · see page 3

    13,992

    Hypertension register

    +8.12% in 3 yrs · England +5.60%

    598

    SMI register

    15% of Wirral (LAD)'s

    1,286

    COPD register

    Reviews -2.20% in 3 yrs

    Forecast to 2030

    16,412

    Hypertension patients, 2030

    +2,420 on today

    78.5%

    QRISK ≥20% on statins, 2030

    +5.95pp over 3 yrs

    7.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,810
    Asthma review coverage fell behind national growth.

    Asthma reviews reached 63.3% (England 65.7%) after falling 1.7% over 2023 to 2025 (England +4.4%), which may reflect recall strain.

    65.8%
    Hypertension treatment to target trails comparators.

    Blood pressure control is 65.8% against 67.9% in Wirral (LAD), 69.1% in the ICB and 70.3% in England, which may reflect review delays.

    77.0%
    Breast and cervical screening exceed national rates.

    Breast screening reaches 77.0% (England 69.9%) and cervical screening reaches 73.3% (England 66.8%), showing strong preventive uptake across the PCN.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over represent 30.9% of the PCN registered population

    Healthier West Wirral PCN serves 67,559 registered patients across five practices. Patients aged 65 and over make up 30.9% of the list (20,911 patients), notably above Wirral (20.7%), NHS Cheshire and Merseyside ICB (19.0%) and England (17.9%). Working-age adults (18–64) comprise 52.9% and children aged 0–17 represent 16.2%. Projected list growth to 2030 is 0.8% under unverified modelling (Wirral 1.2%, ICB 2.3%, England 2.3%). By Census residential estimates, White ethnic groups represent 95.7% (Wirral 95.2%, ICB 93.0%, England 81.1%), leaving an ethnic minority share of 4.3%. High older-age concentration may intensify local frailty and multimorbidity workload.

    Age profile

    0–1716.2%
    18–6452.9%
    65+30.9%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White95.7%
    Asian2.0%
    Mixed1.5%
    Other0.4%
    Black0.3%

    Older people · falls rows are Wirral (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wirral LA)1,5172,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)76.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wirral LA)7531,0219552024/25
    Falls deaths, all ages, per 100,000 (Wirral LA)25.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low overall but Core20 patients concentrate entirely in two practices

    The PCN Core20 share is 4.8%, well below Wirral (LAD) at 34.8%, the ICB at 31.9% and England at 21.0% (average IMD decile 7.8 vs England 5.5). A 0.51 percentage point reconciliation difference exists between PCN (4.8%) and weighted practice share (4.2%). By concentration and volume, registered Core20 patients sit in Myrtle Group Practice (11.4%, estimated 2,361 patients) and Upton Group Practice (6.6%, estimated 504 patients), while three practices record 0.0%. Core20PLUS5 resources must target these two practices rather than spreading PCN funding evenly.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Myrtle11.4% · 2,361 patients
    Upton6.6% · 504 patients
    Marine Lake0.0% · 0 patients
    West Wirral0.0% · 0 patients
    Greasby0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    598

    SMI register

    0.87% recorded prevalence

    318

    Learning disability register

    0.46% recorded prevalence

    32

    Care homes, 1,223 beds

    In the PCN catchment

    10.9%

    Provide unpaid care

    Wirral (LAD), Census 2021

    The PCN records 318 learning disability patients (0.5% prevalence) and 598 severe mental illness patients (0.9%), alongside 32 catchment care homes with 1,223 beds. Both prevalence rates trail Wirral (0.8% and 1.2%), NHS Cheshire and Merseyside ICB (0.6% and 1.1%) and England (0.6% and 1.0%). Lower recorded prevalence does not establish under-detection or unmet need, though proactive annual health checks remain essential.

    Severe mental illness: physical health checks

    PCN SMI blood pressure checks reached 81.7% (England 83.4%), BMI recording 74.4% (England 82.1%), and psychosis alcohol recording 68.3% (England 81.8%). Checks trail at Myrtle Group Practice (75.5%) and Greasby Group Practice (76.0%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    13,992

    Hypertension register

    +8.12%

    Register growth, 3 yrs

    Wirral (LAD) +6.35% · England +5.60%

    +1.67pp

    BP control, under 80

    ≤140/90 · +1.09pp aged 80+

    +2,420

    More patients by 2030

    Forecast 16,412 (23.90%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 20.4% (13,992 patients), exceeding Wirral (18.0%), the ICB (16.8%), and England (15.2%), alongside 3-year growth of +8.1% (England +5.6%). However, blood pressure control trails comparators: 86.6% had a recent reading (England 90.0%) and 65.8% reached target (England 70.3%). By age, control is 62.6% for under-80s (Wirral 66.5%, ICB 66.4%, England 67.8%) and 77.0% for those aged 80+ (Wirral 80.1%, ICB 80.0%, England 81.2%). Crude prevalence is not age-adjusted. Trailing blood pressure control across age cohorts may reflect recall or treatment titration gaps, which clinical audit could test.

    Lipids and statins

    QRISK ≥ 20% lipid therapy reached 64.7% (Wirral 65.8%, ICB 63.2%, England 63.6%), following +10.1% 3-year growth (England +6.2%). Diabetic secondary prevention statin coverage is 81.6%, trailing Wirral (85.1%), the ICB (83.8%), and England (84.4%). Trailing statin coverage in diabetes may reflect review gaps that targeted practice audits could test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026156,192£1.90£1.71£1.86£296,765
    Cardiovascular (all), 2025209,862£6.33£4.37£3.33£1,328,426

    Across 156,192 prescribed items for lipid-regulating drugs (2026), cost per item was £1.90 (Wirral £2.00, ICB £1.71, England £1.86). The PCN spends £29,676 more than at NHS Cheshire and Merseyside Integrated Care Board's unit cost. Higher unit cost than the ICB may reflect formulary choices rather than prescribing inefficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −1.67%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.77%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.5% across 4,933 patients, but annual reviews fell 1.7% over 2023 to 2025 (England +4.4%) to 63.3% (England 65.7%), leaving an estimated 1,810 unreviewed patients. The COPD register expanded +12.1% over 2023 to 2025 to 1,286 patients (prevalence 1.9%, England 1.9%), yet annual reviews fell 2.2% (England +2.8%) to 71.9% (England 76.4%, Wirral 73.2%). Declining reviews alongside register growth may reflect capacity pressure rather than clinical exception.

    Cancer register and children's immunisation

    Cancer QOF prevalence (all ages) is 6.2% at PCN level, exceeding Wirral (4.8%), NHS Cheshire and Merseyside Integrated Care Board (4.3%), and England (3.8%). This difference does not establish under-detection or coding quality; higher recorded prevalence may reflect an older population demographic.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.7%

    England 91.0%

    6-in-1 complete primary course at 24 months99.2%

    England 92.2%

    MMR dose 1 at 24 months96.1%

    England 88.3%

    MMR dose 2 at age 595.0%

    England 82.8%

    4-in-1 pre-school booster at age 594.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Healthier West Wirral PCN records a 6.2% cancer prevalence (4,219 patients), exceeding England's 3.8% and Wirral's 4.8%. PCN breast screening reaches 77.0% (England 69.9%) and cervical screening reaches 73.3% (England 66.8%). For wider system context, NHS Cheshire and Merseyside ICB diagnosed 55.5% of cancers at stage 1 or 2 in 2022 (7,482 of 13,490 with a known stage), compared to England's 55.3% and the 75.0% national ambition by 2028. Known stage was recorded for 72.8% of ICB cancers (13,490 of 18,522; England 67.0%). Strong PCN screening operates within wider ICB early-stage diagnosis constraints, indicating that primary care detection must connect closely with secondary pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Wirral University Teaching Hospital NHS Foundation Trust achieved 77.6% on the 62-day cancer referral to treatment standard against the 85.0% target, above England (71.2%) and below Countess of Chester Hospital NHS Foundation Trust (83.3%). On the 28-day faster diagnosis standard, the trust reached 74.7% against the 75.0% standard (England 79.3%). Trust 6+ week diagnostic waits were 1.5% for MRI and 1.5% for CT (England 21.4% and 9.9%). These provider metrics describe acute system performance rather than PCN delivery; trailing treatment standards alongside low diagnostic waits may reflect downstream secondary care constraints.

    Pathways within standard (%)WirralLiverpoolCountess of ChesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)74.7175.4787.3777.2579.32
    31-day treatment (96%)92.5390.5193.4895.7192.50
    62-day referral to treatment (85%)77.6573.2683.2876.2371.16
    Diagnostic waits over 6 weeks (%)WirralLiverpoolCountess of ChesterEngland
    MRI1.546.4211.2621.40
    CT1.550.714.189.92
    Echocardiography5.0712.5531.4428.48
    Colonoscopy32.8133.1426.4430.83
    Gastroscopy17.7344.9927.5229.02
    All 15 DM01 tests5.0211.5020.1623.14
    Community services activityWirral residentsCheshire and Merseyside ICB
    Care contacts58,870541,280
    Referrals13,31597,150
    Patients with a contact17,205146,240

    Community services (residents of Wirral), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 66.1% of community service contacts among Wirral local authority residents (38,930 of 58,870 contacts). These borough-level resident contacts reflect wider community services activity rather than PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation appears across clinical domain points and childhood MMR dose completion

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Upton1196.669.5%75.8%81.2%
    West Wirral1240.049.1%60.1%77.8%
    Marine Lake1100.050.3%59.4%76.2%
    Greasby1010.048.7%73.6%74.8%
    Myrtle11711.451.6%74.4%66.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWirral (LAD)AssetPCNWirral (LAD)
    Care homes (catchment)32 (1,223 beds)n/aSchools (catchment)71n/a
    Children's centres416Places of worship53171
    Libraries718Primary schools (LA maintained)1252
    Primary academies1436Special schools33

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma review coverage is 63.3% (England 65.7%) and fell 1.7% over 2023 to 2025 (England +4.4%), leaving an estimated 1,810 of 4,933 patients unreviewed. For discussion: the PCN could run structured asthma recall with after-school and flexible slots, starting at the two practices holding all Core20 patients. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension recall and titration clinics

    Across 13,992 hypertension patients (20.4% prevalence), blood pressure control is 65.8% (England 70.3%; Wirral 67.9%) and 62.6% in under-80s (England 67.8%). For discussion: practices could deploy clinical pharmacist-led recall and medicines titration for patients above target, prioritising under-80s in Core20 practices. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Combined chronic disease and SMI recall

    Reviews trail England for heart failure at 67.4% (England 78.5%; 3-year change -3.1% vs +8.7%), COPD at 71.9% (England 76.4%), and SMI BMI at 74.4% (England 82.1%). For discussion: the PCN could combine multimorbidity and SMI reviews, starting at Myrtle Group Practice (75.5%) and Greasby Group Practice (76.0%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Proactive care home multidisciplinary reviews (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sustain cervical screening coverage (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Hypertension recall and titration clinics (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Combined chronic disease and SMI recall (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15